| Literature DB >> 29147933 |
Mu'uz Gebru1, Genene Tefera2, Fufa Dawo3, Tesfaye Sisay Tessema4.
Abstract
A cross-sectional study was conducted to isolate and identify bacterial species from the respiratory tract of apparently healthy and pneumonic camels in Asayita and Dubti woredas in the Afar Region, Ethiopia. From a total of 74 lung tissue and 74 tracheal swab samples Staphylococcus aureus, 16.3%, Streptococcus equi subsp. equi, 13.0%, and Pasteurella multocida, 10.9%, were dominant isolates from pneumonic lungs; Escherichia coli, 12.7%, Proteus species, 10.9%, and Klebsiella pneumoniae, 9.1%, were the majority in the normal lungs. The majority of the isolates colonized both anatomical sites investigated. There was a statistically significant association between the health status of the camels as well as the anatomical site studied with the isolation rates of the major respiratory pathogens (p < 0.05). Furthermore, the isolates were susceptible to norfloxacin, streptomycin, and gentamicin but resistant to ampicillin and tetracycline on in vitro test. Further studies on the pathogenicity of the major isolates are recommended.Entities:
Keywords: Afar; Antibiotic susceptibility; Bacterial; Camel; Lungs
Mesh:
Substances:
Year: 2017 PMID: 29147933 PMCID: PMC7089579 DOI: 10.1007/s11250-017-1476-4
Source DB: PubMed Journal: Trop Anim Health Prod ISSN: 0049-4747 Impact factor: 1.559
Fig. 1Administrative location of Afar region in the country showing the study zone and woredas
Bacterial species isolated from the trachea and lung samples of camels
| Bacterial species | Trachea | Lung | ||||
|---|---|---|---|---|---|---|
| Healthy | Pneumonic | Total | Healthy | Pneumonic | Total | |
|
| 3 (4.5%) | 5 (10.2%) | 8 (7.0%) | 4 (7.5%) | 15 (16.3%) | 19 (12.9%) |
|
| 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (1.8%) | 12 (13.0%) | 13 (8.8%) |
|
| 0 (0.0%) | 1 (2.0%) | 1 (9.0%) | 4 (7.3%) | 10 (10.9%) | 14 (9.5%) |
|
| 0 (0.0%) | 1 (2.0%) | 1 (9.0%) | 2 (3.6%) | 10 (10.9%) | 12 (8.2%) |
|
| 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 8 (8.7%) | 8 (5.4%) |
|
| 8 (12.1%) | 1 (2.0%) | 9 (7.8%) | 5 (9.1%) | 8 (8.7%) | 13 (8.8%) |
|
| 9 (13.6%) | 4 (8.2%) | 13 (11.3%) | 2 (3.6%) | 5 (5.4%) | 7 (4.8%) |
|
| 0 (0.0%) | 1 (2.0%) | 1 (9.0%) | 1 (1.8%) | 5 (5.4%) | 6 (4.1%) |
|
| 7 (10.6%) | 13 (26.5%) | 20 (17.4%) | 7 (12.7%) | 5 (5.4%) | 12 (8.2%) |
|
| 2 (3.0%) | 0 (0.0%) | 2 (1.7%) | 1 (1.8%) | 4 (4.3%) | 5 (3.4%) |
|
| 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 6 (10.9%) | 3 (3.3%) | 9 (6.1%) |
|
| 7 (10.6%) | 3 (6.1%) | 10 (8.7%) | 5 (9.1%) | 3 (3.3%) | 8 (5.4%) |
|
| 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 4 (7.3%) | 1 (1.1%) | 5 (3.4%) |
|
| 7 (10.6%) | 1 (2.0%) | 8 (7.0%) | 3 (5.5%) | 1 (1.1%) | 4 (2.7%) |
|
| 4 (6.1%) | 3 (6.1%) | 7 (6.1%) | 4 (7.3%) | 0 (0.0%) | 4 (2.7%) |
|
| 6 (9.1%) | 2 (4.1%) | 8 (7.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
|
| 1 (1.5%) | 1 (2.0%) | 2 (1.7%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Other | 5 (7.6%) | 2 (4.1%) | 7 (6.1%) | 2 (3.6%) | 0 (0.0%) | 2 (1.4%) |
| Unidentified spp. | 7 (10.6%) | 11 (22.4%) | 18 (15.7%) | 4 (7.3%) | 2 (2.2%) | 6 (1.4%) |
| Total | 66 (100.0%) | 49 (100.0%) | 115 (100.0%) | 55 (100.0%) | 92 (100.0%) | 147 (100.0%) |
CNS, coagulase-negative Staphylococci
Fig. 2Relative proportions of the bacterial isolates in relation to sampling tissues
Fig. 3Bacterial species isolated from the respiratory passageways of apparently healthy and pneumonic camels
Antibiotic susceptibility profiles of bacterial isolates from the respiratory tracts of camels based on the readings on disk diffusion method
| Bacterial species |
| % of isolates sensitive to the antibacterial agents | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMP | E | K | NOR | TE | C | S | CN | VA | DO | ||
|
| 12 | 25.0 | 50.0 | 58.3 | 75.0 | 16.7 | 75.0 | 75.0 | 83.3 | 33.3 | 41.7 |
|
| 11 | 27.2 | 45.5 | 81.8 | 72.3 | 9.1 | 63.6 | 90.9 | 90.9 | 18.2 | 36.4 |
|
| 10 | 40.0 | 50.0 | 30.0 | 90.0 | 20.0 | 70.0 | 100.0 | 80.0 | 10.0 | 60.0 |
|
| 11 | 0.0 | 72.7 | 9.1 | 100.0 | 0.0 | 18.2 | 100.0 | 100.0 | 9.1 | 81.8 |
|
| 17 | 52.0 | 58.8 | 35.3 | 94.1 | 41.2 | 29.4 | 17.6 | 52.9 | 100.0 | 47.1 |
|
| 5 | 0.0 | 80.0 | 0.0 | 100.0 | 20.0 | 40.0 | 80.0 | 40.0 | 100.0 | 60.0 |
|
| 9 | 33.3 | 77.7 | 66.6 | 100.0 | 44.4 | 11.0 | 22.2 | 88.8 | 100.0 | 33.3 |
|
| 10 | 10.0 | 70.0 | 50.0 | 90.0 | 20.0 | 40.0 | 100.0 | 90.0 | 0.0 | 60.0.0 |
|
| 8 | 50.0 | 37.5 | 62.5 | 100.0 | 25.0 | 87.5 | 100.0 | 100 | 12.5 | 75.0 |
|
| 9 | 22.2 | 44.4 | 0.0 | 33.3 | 11.1 | 44.4 | 22.2 | 77.7 | 55.5 | 88.9 |
N, number of isolates tested; AMP, ampicillin; E, erythromycin; K, kanamycin; NOR, norfloxacin; TE, tetracyclin; C, chloramphenicol; S, streptomycin; CN, gentamicin; VA, vancomycin; DO, doxycyclin